<blockquote id="okgnm"></blockquote>
個(gè)人簡(jiǎn)介：
醫(yī)學(xué)博士,，2020年畢業(yè)于廣州中醫(yī)藥大學(xué),，主要從事血管內(nèi)皮祖細(xì)胞治療急性腎損傷的基礎(chǔ)性研究，涉及醫(yī)學(xué)、臨床藥學(xué),、病理學(xué),、細(xì)胞生物學(xué)等多學(xué)科領(lǐng)域,。近五年發(fā)表學(xué)術(shù)論文6篇（2020至今）,，相關(guān)研究成果以第一作者（含共同第一）發(fā)表于Journal of The American Society of Nephrology,、American Journal of Pathology（2021）,、Clinical Pharmacokinetics、Nephrology Dialysis Transplantation,、Front in Immunology,、Front in Genetics。主持國(guó)家自然科學(xué)基金1項(xiàng),、廣東省自然科學(xué)基金1項(xiàng),，以主要骨干身份參與國(guó)家重點(diǎn)研發(fā)計(jì)劃青年科學(xué)家項(xiàng)目1項(xiàng)及國(guó)家級(jí)、省部級(jí),、深圳市課題項(xiàng)目共6項(xiàng),。2021年榮獲“深圳市海外高層次人才（C類(lèi)）”稱(chēng)號(hào)。
教育背景：
2017-09 至 2020-06 廣州中醫(yī)藥大學(xué)與哈佛醫(yī)學(xué)院聯(lián)合培養(yǎng),，醫(yī)學(xué)博士
2014-09 至 2017-06 廣州中醫(yī)藥大學(xué),，醫(yī)學(xué)碩士
2009-09 至 2014-06 山西中醫(yī)藥大學(xué)，醫(yī)學(xué)學(xué)士
工作經(jīng)歷：
2023-11至今 南方科技大學(xué),，醫(yī)學(xué)院,，研究助理教授
2022-11至2023-11 南方科技大學(xué)，醫(yī)學(xué)院,，高級(jí)研究學(xué)者
2020-10至2022-11 南方科技大學(xué),，醫(yī)學(xué)院，博士后
獲獎(jiǎng)情況及榮譽(yù)：
2021年榮獲“深圳市海外高層次人才（C類(lèi)）”稱(chēng)號(hào),。
2018年榮獲廣州中醫(yī)藥大學(xué)“國(guó)際交流項(xiàng)目”資助公派出國(guó)深造,。
研究領(lǐng)域：
利用黑色素瘤循環(huán)腫瘤細(xì)胞探索癌轉(zhuǎn)移的分子生物學(xué)機(jī)制
發(fā)表論文：
Jialing Liu*; Yi Li*; Lingna Lyu; Liang Xiao; Aliza Anwar Memon; Xin Yu; Arvin Halim; Shivani Patel; Abdikheyre Osman; Wenqing Yin; Jie Jiang; Said Naini; Kenneth Lim; Aifeng Zhang; Jonathan Williams; Ruth Koester; Kevin Zeng Qi; Quynh-Anh Fucci; Lai Ding; Steven Chang; Ankit Patel; Yutaro Mori; Advika Chaudhari; Aaron Bao; Jia Liu; Tzongshi Lu; Andrew Siedlecki; Integrin alpha-5 is regulated by miR- 218-5p in endothelial progenitor cells, Journal of The American Society of Nephrology, 2022, 33(3): 565-582. (*Equal contributions)
Jialing Liu*; Yanmei Zhang*; Hongqin Sheng*; Chunling Liang; Huazhen Liu;Jose Alberto Moran Guerrero; Zhaoyu Lu; Wei Mao; Zhenhua Dai?; Xusheng Liu?; Lei Zhang?; Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice with Type 2 Diabetes Mellitus, Frontiers in Immunology, 2021.12. (*Equal contributions; ? co-corresponding authors)
Wang, Xiaojie*; Liu, Jialing*; Yin, Wenqing; Abdi, Farhiya; Pang, Paul D; Fucci, Quynh-Anh;Abbott, Molly; Chang, Steven L; Steele, Graeme; Patel, Ankit; Mori, Yutaro; Zhang, Aifeng; Zhu, Shikai; Lu, Tzong-Shi; Kibel, Adam S; Wang, Bin; Lim, Kenneth; Siedlecki, Andrew M; miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature, The American Journal of Pathology, 2020, 190(3): 642-659. (*Equal contributions)
Jialing Liu; Aliza Anwar Memon; Lingna Lyu; Andrew Siedlecki; Comment on “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”, Clinical Pharmacokinetics, 2020, 59(12): 1641-1643.
Jialing Liu; Jingru Lian; Yafei Chen; Xin Zhao; ChangZheng Du; Yang Xu; Hailiang Hu; Hai Rao; Xin Hong; Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response. Frontiers in Genetics, 2021, 12.
